small molecule therapeutics for cardiovascular disease

History:

They were acquired by Gilead in 2009.

Employment

Email:

Fax:

Mail:

General Info:

Ticker: CVTX

Employees:

Regions:
Northern California

Research Focus:
Disease Therapeutics-Research Therapeutics-Development Therapeutics-Clinical early (I, II) Therapeutics:Clinical late (III)

 

Profiles:

 

News:

Keywords: 

Strategic Partnerships: